28 related articles for article (PubMed ID: 31587598)
1. Is imiquimod a promising drug to treat oral mucosa diseases? A scoping review and new perspectives.
de Mello Palma V; Frank LA; Balinha DM; Rados PV; Pohlmann AR; Guterres SS; Visioli F
Br J Clin Pharmacol; 2024 Feb; 90(2):427-439. PubMed ID: 37817570
[TBL] [Abstract][Full Text] [Related]
2. Skin Penetration Enhancement Strategies Used in the Development of Melanoma Topical Treatments.
Tambunlertchai S; Geary SM; Salem AK
AAPS J; 2021 Jan; 23(1):19. PubMed ID: 33404992
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial Peptide Designing and Optimization Employing Large-Scale Flexibility Analysis of Protein-Peptide Fragments.
Kumar N; Sood D; Tomar R; Chandra R
ACS Omega; 2019 Dec; 4(25):21370-21380. PubMed ID: 31867532
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effect of Imiquimod enhanced ALA-PDT on cutaneous squamous cell carcinoma.
Bhatta AK; Wang P; Keyal U; Zhao Z; Ji J; Zhu L; Wang X; Zhang G
Photodiagnosis Photodyn Ther; 2018 Sep; 23():273-280. PubMed ID: 30030167
[TBL] [Abstract][Full Text] [Related]
5. Self-assembled mPEG-hexPLA polymeric nanocarriers for the targeted cutaneous delivery of imiquimod.
Lapteva M; Mignot M; Mondon K; Möller M; Gurny R; Kalia YN
Eur J Pharm Biopharm; 2019 Sep; 142():553-562. PubMed ID: 30641138
[TBL] [Abstract][Full Text] [Related]
6. Microemulsions based on TPGS and isostearic acid for imiquimod formulation and skin delivery.
Pescina S; Garrastazu G; Del Favero E; Rondelli V; Cantù L; Padula C; Santi P; Nicoli S
Eur J Pharm Sci; 2018 Dec; 125():223-231. PubMed ID: 30316975
[TBL] [Abstract][Full Text] [Related]
7. Imiquimod inhibits melanoma development by promoting pDC cytotoxic functions and impeding tumor vascularization.
Aspord C; Tramcourt L; Leloup C; Molens JP; Leccia MT; Charles J; Plumas J
J Invest Dermatol; 2014 Oct; 134(10):2551-2561. PubMed ID: 24751730
[TBL] [Abstract][Full Text] [Related]
8. Imiquimod-oleic acid prodrug-loaded cream reduced drug crystallinity and induced indistinguishable cytotoxicity and apoptosis in mice melanoma tumour.
Sharma A; Sharma D; Baldi A; Jyoti K; Chandra R; Madan J
J Microencapsul; 2019 Dec; 36(8):759-774. PubMed ID: 31587598
[TBL] [Abstract][Full Text] [Related]
9. Topical treatment of melanoma skin metastases with imiquimod: a review.
Sisti A; Sisti G; Oranges CM
Dermatol Online J; 2015 Feb; 21(2):. PubMed ID: 25756475
[TBL] [Abstract][Full Text] [Related]
10. Mediators of Inflammation in Topical Therapy of Skin Cancers.
Voiculescu VM; Lisievici CV; Lupu M; Vajaitu C; Draghici CC; Popa AV; Solomon I; Sebe TI; Constantin MM; Caruntu C
Mediators Inflamm; 2019; 2019():8369690. PubMed ID: 30766448
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]